GSK Seeks Mid-Sept Bids For $4 Billion Indian Horlicks Unit
GlaxoSmithKline is seeking initial bids by mid-September for its India-focussed Horlicks health nutrition business, which is expected to fetch more than $4 billion (€ 3.5 billion), experts said on Tuesday.
The British drugmaker started a strategic review of Horlicks, a popular malt-based drink in India, and some smaller products, after buying Novartis out of their consumer healthcare venture for $13 billion (€11.3 billion) in March.
Try European Supermarket Magazine PREMIUM – 30 Day FREE Trial.
A trial subscription gives unrestricted access to all premium site content, app content, weekly email content and European Supermarket Magazine digital edition for a full 30 days. Try it now!